We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Financials 13%
3 Technology 12.06%
4 Communication Services 9.43%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMAC.WS
276
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$53K ﹤0.01%
+62,500
New +$42.5K
AEON.WS
277
DELISTED
AEON Biopharma Inc
AEON.WS
$50K ﹤0.01%
+49,995
New +$37.9K
ANAC.WS
278
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$50K ﹤0.01%
+50,000
New +$42.7K
LDHAW
279
DELISTED
LDH Growth Corp I Warrant
LDHAW
$49K ﹤0.01%
+30,000
New +$33.1K
ASPCW
280
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$33K ﹤0.01%
+39,799
New +$24.9K
RUMBW
281
RUM Group Inc Warrant
RUMBW
$13.8M
$25K ﹤0.01%
+25,000
New +$22.5K
NSTD.WS
282
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$24K ﹤0.01%
+16,666
New +$17.9K
NSTC.WS
283
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$21K ﹤0.01%
+16,667
New +$17.9K
SLAMW
284
DELISTED
Slam Corp. warrant
SLAMW
$19K ﹤0.01%
+17,627
New +$16.4K
SPAQ.WS
285
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$18K ﹤0.01%
+15,013
New +$15.8K
ACRS icon
286
Aclaris Therapeutics
ACRS
$869M
– –
-100,000
Closed -$2.52M
ADVM
287
DELISTED
Adverum Biotechnologies
ADVM
– –
-150,000
Closed -$14.8M
AFMD
288
DELISTED
Affimed
AFMD
– –
-50,000
Closed -$3.96M
BOLT icon
289
Bolt Biotherapeutics
BOLT
$7.78M
– –
-12,500
Closed -$8.23M
CGEM icon
290
Cullinan Oncology
CGEM
$1.14B
– –
-125,000
Closed -$5.21M
CNTB
291
Connect Biopharma Holdings
CNTB
$139M
– –
-400,000
Closed -$7.4M
CRIS icon
292
Curis
CRIS
$7.83M
– –
-2,500
Closed -$11.3M
EQ icon
293
Equillium
EQ
$133M
– –
-680,000
Closed -$4.86M
FOLD
294
DELISTED
Amicus Therapeutics
FOLD
– –
-100,000
Closed -$988K
INNV icon
295
InnovAge Holding
INNV
$1.52B
– –
-200,000
Closed -$5.16M
IONS icon
296
Ionis Pharmaceuticals
IONS
$9.4B
– –
-630,500
Closed -$28.3M
LNTH icon
297
Lantheus
LNTH
$6.59B
– –
-2,250,000
Closed -$48.1M
SAGE
298
DELISTED
Sage Therapeutics
SAGE
– –
-345,000
Closed -$25.8M
SRPT icon
299
Sarepta Therapeutics
SRPT
$1.77B
– –
-300,000
Closed -$22.4M
ZYME icon
300
Zymeworks
ZYME
$1.67B
– –
-600,000
Closed -$18.9M
10 11
12
13 14

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Farallon Capital Management held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Farallon Capital Management deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Farallon Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Farallon Capital Management's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Farallon Capital Management fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Farallon Capital Management opened 164 new positions and closed 100 in Q2 2021.
  • Farallon Capital Management's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.